Yeah exactly
(Don't forget TAVR is an extremely complex product)
And there is also competition.. from massive tech companies right?
But whatever... this management team has "the form"!!!!... (look mum no ADAPT!)
But "I'm clueless"
And so is the market!
....At the end of the day all RI's are "clueless" and the big inhouse boys and "corps" know everything!
...So Sick of the bully boys (again)
Cheerio and good luck with it.
Ann: CardioCel and VascuCel rights sold to LeMaitre Vascular, page-113
-
- There are more pages in this discussion • 177 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.31 |
Change
-0.240(1.29%) |
Mkt cap ! $351.9M | |||
| Open | High | Low | Value | Volume |
| $18.80 | $19.15 | $18.20 | $159.7K | 8.611K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 73 | $18.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.33 | 90 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| AVR (ASX) Chart |